Follicular Lymphoma

general

A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correl

86

Centers

368

Active Trials

$2.3B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Follicular Lymphoma(86)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.4
2
NCI Comprehensive
High-Volume Research Center
88.0
378.9
4
NCI Comprehensive
High-Volume Research Center
77.9
5
NCI Comprehensive
High-Volume Research Center
74.8
6
NCI Comprehensive
High-Volume Research Center
73.5
7
NCI Clinical
High-Volume Research Center
71.7
8
NCI Comprehensive
Active Research Program
68.1
9
NCI Comprehensive
Active Research Program
68.0
10
NCI Comprehensive
Active Research Program
67.1
11
NCI Comprehensive
Active Research Program
65.9
12
Active Research Program
65.9
13
NCI Comprehensive
Active Research Program
65.3
14
NCI Comprehensive
Active Research Program
64.8
15
Active Research Program
64.8
16
NCI Comprehensive
Active Research Program
63.5
17
NCI Comprehensive
Active Research Program
63.3
18
Active Research Program
63.3
19
NCI Comprehensive
Active Research Program
62.1
20
NCI Comprehensive
Active Research Program
61.9
21
NCI Comprehensive
Active Research Program
58.9
22
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
58.9
23
NCI Comprehensive
Active Research Program
58.9
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
58.9
25
Active Research Program
58.9
26
BC CancerVancouver, BC
Active Research Program
58.9
27
Active Research Program
58.9
28
NCI Clinical
Active Research Program
58.2
29
NCI Clinical
Active Research Program
54.8
30
Active Research Program
54.8
31
NCI Comprehensive
Active Research Program
54.6
3251.6
33
NCI Comprehensive
Active Research Program
50.6
34
NCI Comprehensive
Active Research Program
49.9
35
NCI Comprehensive
Active Research Program
49.9
36
NCI Comprehensive
Active Research Program
49.9
37
Active Research Program
49.9
38
NCI Clinical
Active Research Program
49.9
39
Active Research Program
49.9
40
Active Research Program
49.9
41
Active Research Program
49.9
42
Active Research Program
49.9
43
Active Research Program
49.3
44
NCI Comprehensive
Active Research Program
48.4
45
NCI Comprehensive
Active Research Program
47.9
46
NCI Comprehensive
Active Research Program
45.6
4745.2
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
43.8
49
NCI Comprehensive
Active Research Program
41.1
50
NCI Clinical
Active Research Program
40.5
51
NCI Comprehensive
Active Research Program
40.5
52
NCI Comprehensive
Active Research Program
40.5
53
NCI Comprehensive
Active Research Program
40.5
54
NCI Comprehensive
Active Research Program
40.5
55
NCI Comprehensive
Active Research Program
40.5
56
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
40.5
57
NCI Basic_laboratory
Active Research Program
40.5
58
NCI Comprehensive
Active Research Program
40.5
59
NCI Comprehensive
Active Research Program
40.5
60
Active Research Program
40.5
61
Active Research Program
40.5
6240.5
63
Active Research Program
40.5
64
Active Research Program
40.5
65
Active Research Program
40.5
6628.8
6728.8
6828.8
69
NCI Comprehensive
28.8
70
NCI Comprehensive
28.8
71
NCI Comprehensive
28.8
72
NCI Clinical
28.8
7328.8
74
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
28.8
7528.8
7628.8
7728.8
78
NCI Comprehensive
79
NCI Comprehensive
80
81
NCI Clinical
82
83
NCI Comprehensive
84
NCI Comprehensive
85
86

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →